All News
RAPID3 in Assessing Psoriatic Arthritis
My research shows that up to 50% of rheumatologists measure something in the course of their daily assessments, and RAPID3 is most popular, being employed by 31% of rheumatologists.
Read Article
Top vasculitis takeaways from ACR 2021
There were several hot topics at ACR21. Here I concentrate on top abstracts in vasculitis.
Read Article
GLORIA Study - Is Prednisone Harmful in Elder RA?
The GLORIA study (ABST# 1678) was a pragmatic, blinded placebo-controlled randomized trial from Dr. Martin Boers and colleagues where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
Read Article
Redefining Aging
The American College of Rheumatology put together the Community Aging Hub and multiple sessions to help rheumatologists identify gaps in care for older patients with rheumatic diseases
https://t.co/9ciS6oDncK https://t.co/oPZrFU0dmQ
Links:
Dr. John Cush RheumNow ( View Tweet)
GLORIA Study - Is Prednisone Harmful in Elder RA?
The GLORIA study (ABST#1678) was a pragmatic, blinded placebo-controlled randomized trial where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
https://t.co/eKXjiDpHlc https://t.co/JtCgc1uZnE
Links:
Dr. John Cush RheumNow ( View Tweet)
Osteoporosis in PsA: Dr. Rachel Tate ( @uptoTate) discusses Abstract #1325, presented at the #ACR21 annual meeting.
https://t.co/xnRkPnHeTr https://t.co/nE3ehhCB4j
Links:
Dr. John Cush RheumNow ( View Tweet)
Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts #0811 and #0373 presented at the #ACR21 annual meeting.
https://t.co/2qeZjhtMU4 https://t.co/MPCA3oox1U
Links:
Dr. John Cush RheumNow ( View Tweet)
Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/WVgcE8TVpZ https://t.co/1uOafjFWPg
Links:
Dr. John Cush RheumNow ( View Tweet)
RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi ( @MeralElRamahiMD) reports on abstract #0633 presented at the #ACR21 annual meeting.
https://t.co/DO7YXhD3YA https://t.co/vcegdPx8OL
Links:
Dr. John Cush RheumNow ( View Tweet)
First JAKi Failure: What next? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #1442 presented at the #ACR21 annual meeting.
https://t.co/NCO8VeNsjb https://t.co/bSN34AFTtt
Links:
Dr. John Cush RheumNow ( View Tweet)
Career Advice for Young Rheumatologists: Drs. Janet Pope ( @Janetbirdope) asks Dr. Bykerk for her career advice for young rheumatologists, during the #ACR21 annual meeting.
https://t.co/jv0eYeFR7M https://t.co/WfYFXPwMtI
Links:
Dr. John Cush RheumNow ( View Tweet)
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/jWDeA2aZqJ
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/KcE67BXcvp
Links:
Dr. John Cush RheumNow ( View Tweet)
TNF Inhibitors Rise to the Top: Drs. Janet Pope ( @Janetbirdope) and David Liew ( @drdavidliew) discuss TNF inhibitor data presented at the #ACR21 annual meeting, including abstracts #0087, #0990 and #0958.
https://t.co/G02P1vG7VQ https://t.co/BLZX5BPzEF
Links:
Dr. John Cush RheumNow ( View Tweet)
Data from ASN Kidney Wk 2021; US Renal Data System of 275,651 dialysis pts - 15% had gout Vs 85% without gout; Gout pts were older, more male, obese, had more hospitalizations (66 vs 57%), mortality, more CVD, PVD and MI https://t.co/m1d0SJEJjw
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of SpA Abstracts Day 2: Dr. Robert Chao ( @doctorRBC) shares the best of SpA Abstracts from Day 2 of #ACR21.
https://t.co/8oZipxMLCm https://t.co/jAifqBRgVc
Links:
Dr. John Cush RheumNow ( View Tweet)
Early Rheumatoid Arthritis: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Vivian Bykerk about her work in early RA and CATCH (Canadian Early Arthritis Cohort) Study Group, during the #ACR21 annual meeting.
https://t.co/DGazNdTFTU https://t.co/K318MIkxvy
Links:
Dr. John Cush RheumNow ( View Tweet)
Vitamin D and Hydroxychloroquine Studies: Dr. Michelle Petri discussed studies regarding Vitamin D supplementation and as well as data on hydroxychloroquine that was presented Saturday at the #ACR21 annual meeting.
https://t.co/CU8wFVYhNg
Links:
Dr. John Cush RheumNow ( View Tweet)
Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases: Dr. Chao ( @doctorRBC) discusses abstract #0957 presented at the #ACR21 annual meeting.
https://t.co/h6CpY1Zn2r https://t.co/hebsz6tge3
Links:
Dr. John Cush RheumNow ( View Tweet)
Find all our #ACR21 podcast coverage here.
https://t.co/zcdUCwbjsH https://t.co/VQbwT2WcfZ
Links:
Dr. John Cush RheumNow ( View Tweet)
An Old Friend – Methotrexate in Psoriatic Arthritis
Methotrexate (MTX) remains one of our most used and reliable tools against a variety of rheumatic diseases, particularly in the care of peripheral arthritis such as PsA.
https://t.co/zIsbL3KFlZ
#ACR21 @_Castillo_Pedro https://t.co/Efm2kAx85x
Links:
Dr. John Cush RheumNow ( View Tweet)